www.fda.gov

• 
  
  
  
  

  
  






• Guidance for Industry: Testing of Glycerin for Diethylene Glycol :: fda guidance
  Guidance for Industry:Testing of Glycerin for Diethylene Glycol
  

  Apercu : An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. A staff responsible for implementing this guidance. A staff, call the appropriate number listed on the title page of this

  Voir Guidance for Industry: Testing of Glycerin for Diethylene Glycol
• U.S. FDA CDER Home Page :: fda, fda drug, fda gov
  FDA/Center for Drug Evaluation and Research Home Page
  

  Apercu : Zelnorm (tegaserod maleate) for qualifying patients. Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis). Lyrica (pregabalin), the first drug to treat fibromyalgia, a disorder characterized by pain, fati

  Voir U.S. FDA CDER Home Page
• Information about the Products We Regulate :: fda drug, fda drug
  Drug Information
  

  Apercu : This is a current listing of new cancer drugs. It is updated on a monthly basis. Information for consumers and industry about non-prescription drugs. Contact the manufacturer for the complete labeling/package insert. This article describes the dr

  Voir Information about the Products We Regulate
• Guidance for Institutional Review Boards and Clinical Investigators :: fda guidance
  FDA Information Sheets: 1998 Update - This document represents the agency's current guidance on protection of human subjects of research. It is published as a level 2 guidance in accordance with the FDA good guidance practices.
  

  Apercu : Sheets will be revised and updated as needed. The date of the most recent revision is listed next to the title. Learn more about this initiative.

  Voir Guidance for Institutional Review Boards and Clinical Investigators
• Guidance for Institutional Review Boards and Clinical Investigators :: fda guidance, fda guidelines
  FDA Information Sheets: 1998 Update - This document represents the agency's current guidance on protection of human subjects of research. It is published as a level 2 guidance in accordance with the FDA good guidance practices.
  

  Apercu : Sheets will be revised and updated as needed. The date of the most recent revision is listed next to the title. Learn more about this initiative.

  Voir Guidance for Institutional Review Boards and Clinical Investigators
• FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1 :: fda approval

  Apercu : April 19 due to changes in the last paragraph. A virus commonly found in birds. A in the near future.

  Voir FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1
• Guidance Page :: fda guidance
  FDA/Center for Drug Evaluation and Research General Page
  

  Apercu : Agency perspective on an issue.

  Voir Guidance Page
• Food and Drug Administration Home Page :: fda, fda drug, fda approval, fda gov
  Home Page for the Food and Drug Administration (FDA)
  Voir Food and Drug Administration Home Page
• FDA/CBER Guidances, Guidelines, Points to Consider :: fda guidelines Voir FDA/CBER Guidances, Guidelines, Points to Consider
• FDA Recalls, Market Withdrawals and Safety Alerts :: fda gov Voir FDA Recalls, Market Withdrawals and Safety Alerts
• Generic Drugs: Questions and Answers :: fda guidelines
  Frequently Asked Questions about Generic Drugs
  Voir Generic Drugs: Questions and Answers
• Liptor- Imported Drugs with Various Safety Concerns :: liptor
  Liptor Photo
  Voir Liptor-Imported Drugs with Various Safety Concerns